Clinical and Translational Radiation Oncology

Slides:

Advertisements

Similar presentations

Ten Year Outcomes In Men Under 60 Treated With Iodine-125 Permanent Brachytherapy As Monotherapy GU - Prostate Cancer: Novel Imaging (MRI,PET) & Brachytherapy.

Advertisements

2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.

Use of the insulin pump in treat cystic fibrosis related diabetes Dana S. Hardin, Julie Rice, Mark Rice, Randall Rosenblatt Journal of Cystic Fibrosis.

Fuhrman Grade and Neutrophil-To-Lymphocyte Ratio Influence on Survival in Patients With Metastatic Renal Cell Carcinoma Treated With First-Line Tyrosine.

The cost of diabetes and diabetes care

A Royal College of Radiologists National Audit of Radiotherapy in the Treatment of Metastatic Spinal Cord Compression and Implications for the Development.

18Fluorodeoxyglucose PET Is Prognostic of Progression-Free and Overall Survival in Locally Advanced Pancreas Cancer Treated With Stereotactic Radiotherapy

Combination chemotherapy with bevacizumab and S-1 for elderly patients with metastatic colorectal cancer (BASIC trial) M. Yoshida, K. Muro, A. Tsuji,

Morten Hoyer, Ph. D. , Henrik Roed, D. M. Sc

Split-Course Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Single-Institution Experience of 144 Patients Benjamin T. Gielda, MD,

A Clinical Prognostic Index for Patients Treated with Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 Marie Florescu,

Incidence and clinical impact of chemotherapy induced myelotoxicity in cancer patients: An observational retrospective survey Lazzaro Repetto Critical.

Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases Isabelle Thibault, MD, Mikki Campbell,

Perceptions of general practitioners on initiation and intensification of type 2 diabetes injectable therapies. A quantitative study in the United Kingdom

A 45-SNP genetic risk score is increased in early-onset coronary artery disease but independent of familial disease clustering Morten K. Christiansen,

Trine Grantzau, Mette Skovhus Thomsen, Michael Væth, Jens Overgaard

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced.

Volume 53, Issue 5, Pages (May 2008)

Volume 62, Issue 6, Pages (December 2012)

Single nucleotide polymorphisms might influence chemotherapy induced nausea in women with breast cancer Delmy Oliva, Mats Nilsson, Bengt-Åke Andersson,

Zachary S. Morris, MD, PhD, Donald M. Cannon, MD, Brett A

Tumor volume predicts local recurrence in early rectal cancer treated with radical resection: A retrospective observational study of 270 patients Yanhui.

Split-Course Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: A Single-Institution Experience of 144 Patients Benjamin T. Gielda, MD,

Volume 146, Issue 3, Pages (September 2017)

Pain in cancer survivors; filling in the gaps

David J. Brenner, Eric J. Hall, Rochelle E. Curtis, Elaine Ron

Aspirin in the prevention of cancer – Author's reply

Gerry H. Tan, M.D., Roger L. Nelson, M.D. Mayo Clinic Proceedings

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

A Clinical Prognostic Index for Patients Treated with Erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21 Marie Florescu,

Patient-reported symptoms and performance status before palliative radiotherapy in geriatric cancer patients (octogenarians) Carsten Nieder, Thomas A.

Surgery vs. primary radiotherapy in early-stage oropharyngeal cancer

IA05.01 Lung Cancer Cases Journal of Thoracic Oncology

VMAT radiation-induced nausea and vomiting in adjuvant breast cancer radiotherapy: The incidental effect of low-dose bath exposure G. Lazzari, A. Terlizzi,

Y. Maor, N. Belausov, D. Ben-David, G. Smollan, N. Keller, G. Rahav

Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller Jung-Jyh Hung, MD, PhD, Yi-Chen Yeh, MD, Yu-Chung Wu,

Volume 53, Issue 1, Pages (January 2008)

Improved Overall Survival with Aggressive Primary Tumor Radiotherapy for Patients with Metastatic Esophageal Cancer David M. Guttmann, MD, MTR, Nandita.

Photodynamic Therapy for Early Stage Central Type of Lung Cancer

Clinical and Translational Radiation Oncology

Clinical and Translational Radiation Oncology

Cone beam computed tomography-based monitoring and management of target and organ motion during external beam radiotherapy in cervical cancer Nina Boje.

Lung Cancer and Prognosis in Taiwan: A Population-Based Cancer Registry Bing-Yen Wang, MD, Jing-Yang Huang, Ching-Yuan Cheng, MD, Ching-Hsiung Lin, MD,

Survival and failure types after radiation therapy of vulvar cancer

Evaluating the prevalence and predictive factors of vasomotor and psychological symptoms in prostate cancer patients receiving hormonal therapy: Results.

Impact of waiting time on nodal staging in head and neck squamous-cell carcinoma treated with radical intensity modulated radiotherapy Cédric Chevalier,

Jean-Emmanuel Bibault, Ingeborg Tinhofer

What is the impact of diabetes mellitus on radiation induced acute proctitis after radical radiotherapy for adenocarcinoma prostate? A prospective longitudinal.

Nivolumab-Induced Acute Diabetes Mellitus and Hypophysitis in a Patient with Advanced Pulmonary Pleomorphic Carcinoma with a Prolonged Tumor Response

U.S. Hospice Benefits Journal of Pain and Symptom Management

Prognostic impact of leukocyte counts before and during radiotherapy for oropharyngeal cancer Garrett L. Jensen, Pierre Blanchard, G. Brandon Gunn, Adam.

Helen Barraclough, MSc, Ramaswamy Govindan, MD

The posterior cerebellum, a new organ at risk?

Should Large Cell Neuroendocrine Lung Carcinoma be Classified and Treated as a Small Cell Lung Cancer or with Other Large Cell Carcinomas? John M. Varlotto,

Differences in patterns of care and outcomes between grade II and grade III molecularly defined 1p19q co-deleted gliomas Debra Nana Yeboa, James B. Yu,

Rectal volume variations and estimated rectal dose during 8 weeks of image-guided radical 3D conformal external beam radiotherapy for prostate cancer

Plasma proteins as prognostic biomarkers in radiotherapy treated head and neck cancer patients Line Brøndum, Jesper Grau Eriksen, Brita Singers Sørensen,

The Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Lung Cancer: Still Following the Right TRAIL? Emmet E. McGrath, MB, PhD Journal of Thoracic.

Differential impacts of modes of anaesthesia on the risk of stroke among preeclamptic women who undergo Caesarean delivery: a population-based study

International Thymic Malignancies Interest Group: A Way Forward

Radiation dose mapping and anastomotic complications after trimodality therapy for esophageal cancers Andrew Bang, Joel A. Broomfield, Jessica Chan,

Stage I Non-small Cell Lung Cancer: Results for Surgery in a Patterns-of-Care Study in Sydney and for High-Dose Concurrent End-Phase Boost Accelerated.

J. Carlisle, M. Swart, E.J.C. Dawe, M. Chadwick

Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: a retrospective cohort study H Ismail,

Kaplan-Meier survival analysis for all-cause and CVD mortality in 2,823 type 2 diabetic patients stratified by CKD according to each creatinine-based equation.

Association of opioid requirement and cancer pain with survival in advanced non-small cell lung cancer D. Zylla, M.A. Kuskowski, K. Gupta, P. Gupta

Clinical and Translational Radiation Oncology

Esophagectomy for T1 Esophageal Cancer: Outcomes in 100 Patients and Implications for Endoscopic Therapy Arjun Pennathur, MD, Andrew Farkas, BA, Alyssa.

Effect of Tumor Size on Prognosis in Patients Treated with Radical Radiotherapy or Chemoradiotherapy for Non–Small Cell Lung Cancer: An Analysis of the.

Michael Yan, Weidong Kong, Andrew Kerr, Michael Brundage

Presentation transcript:

Clinical and Translational Radiation Oncology The influence on survival of glucocorticoid induced diabetes in cancer patients with metastatic spinal cord compression Helga Schultz, Ulrik Pedersen-Bjergaard, Andreas Kryger Jensen, Svend Aage Engelholm, Peter Lommer Kristensen Clinical and Translational Radiation Oncology Volume 11, Pages 19-25 (June 2018) DOI: 10.1016/j.ctro.2018.04.004 Copyright © 2018 The Author(s) Terms and Conditions

Fig. 1 Illustration of the multistate model. Clinical and Translational Radiation Oncology 2018 11, 19-25DOI: (10.1016/j.ctro.2018.04.004) Copyright © 2018 The Author(s) Terms and Conditions

Fig. 2 Survival based on primary tumor in 131 patients with metastatic spinal cord compression treated with high doses of glucocorticoids and followed for a mean of 355 days. The numbers under the figure refer to the number of patients at risk at the time points above stratified by tumor group. Clinical and Translational Radiation Oncology 2018 11, 19-25DOI: (10.1016/j.ctro.2018.04.004) Copyright © 2018 The Author(s) Terms and Conditions

Fig. 3 Nonparametric estimates of the transition probabilities to death according to three states: No diabetes, diabetes by definition and insulin treated diabetes. Clinical and Translational Radiation Oncology 2018 11, 19-25DOI: (10.1016/j.ctro.2018.04.004) Copyright © 2018 The Author(s) Terms and Conditions

Fig. 4 Sensitivity analysis. A log-rank test showed that patients who had at least one glucose measurement >15 mmol/l (n = 17) had statistically significant worse survival, p = 0.00639. This analysis only included patients with HbA1c <48 mmol/mol. Clinical and Translational Radiation Oncology 2018 11, 19-25DOI: (10.1016/j.ctro.2018.04.004) Copyright © 2018 The Author(s) Terms and Conditions